Traws Pharma (TRAW) Goodwill & Intangibles (2025 - 2026)

Traws Pharma (TRAW) posted quarterly Goodwill & Intangibles of $2.6 million for Q1 2026, up 2.3% quarter-over-quarter from $2.5 million in Q4 2025.

Traws Pharma (TRAW) Goodwill & Intangibles (2025 - 2026) Analysis & Trends

Traws Pharma (TRAW) has reported Goodwill & Intangibles for 2 consecutive years, with $2.6 million the latest figure, recorded in Q1 2026.

In Q1 2026, Goodwill & Intangibles changed N/A year-over-year to $2.6 million; the TTM figure through Mar 2026 stood at $2.6 million (changed N/A YoY), while the FY2025 annual figure was $2.5 million, changed N/A from the prior year.
Goodwill & Intangibles grew to $2.6 million in Q1 2026 per TRAW's latest filing, from $2.5 million in the prior quarter.
Across five years, Goodwill & Intangibles topped out at $2.6 million in Q3 2025 and bottomed at $2.5 million in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-
10	Traws Pharma	5.66 Mn	639,491.99	-

Download Data